Pedro J. Lasanta - Mar 6, 2023 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role
Chief Financial Officer
Signature
/s/ Pedro J. Lasanta
Stock symbol
PBSV
Transactions as of
Mar 6, 2023
Transactions value $
-$1
Form type
4
Date filed
3/8/2023, 03:23 PM
Previous filing
Dec 13, 2021
Next filing
Dec 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBSV Common Stock Options Exercise $88K +100K +105.76% $0.88 195K Mar 6, 2023 Direct
transaction PBSV Common Stock Tax liability -$88K -76.5K -39.33% $1.15 118K Mar 6, 2023 Direct F1
transaction PBSV Common Stock Options Exercise $8.24K +8.33K +7.05% $0.99 126K Mar 6, 2023 Direct
transaction PBSV Common Stock Tax liability -$8.24K -7.17K -5.67% $1.15 119K Mar 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBSV Stock Option Options Exercise $0 -100K -100% $0.00* 0 Mar 6, 2023 Common Stock 100K $0.88 Direct F2
transaction PBSV Stock Option Options Exercise $0 -8.33K -33.3% $0.00 16.7K Mar 6, 2023 Common Stock 8.33K $0.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2 The stock option vested in three equal annual installments beginning on October 4, 2020.
F3 On December 9, 2021, the reporting person was granted a stock option to purchase 25,000 shares, which stock option vests in three equal installments beginning on December 9, 2022.